Exagen XGN 深 沪
等待开盘 08-10 09:30:00 美东时间
6.87
+0.280
+4.25%
华盛通- 最 高7.10
- 今 开6.68
- 成交量 43.11万股
- 最 低 5.74
- 昨 收 6.59
- 总市值 11.17万
- 52周最高 12.23
- 市盈率 静 --
- 换手率 2652.16%
- 52周最低 2.59
- 委 比 44.40%
- 总股本 1.63万
- 历史最高 29.858
- 量 比 0.46
- 振 幅 20.64%
- 历史最低 1.10
- 每 手 1
- 风险率 2.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Exagen Affirms FY2026 Sales Guidance of $70.000M-$73.000M vs $71.267M Est
Exagen (NASDAQ:XGN) affirms FY2026 sales outlook from $70.000 million-$73.000 million to $70.000 million-$73.000 million vs $71.267 million estimate.
05-11 20:03
Earnings Scheduled For May 11, 2026
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
Exagen Inc. appoints Dr. Michael Mahler as Chief Scientific Officer. With a strong background in immunology, Mahler, who earned his Ph.D. at the University of Heidelberg and previously served at Werfen, brings extensive expertise in autoimmune research and diagnostics. His addition aims to strengthen Exagen's diagnostic capabilities and patient care advancements.
2025-06-23 13:00
Exagen Q4 2024 GAAP EPS $(0.20) Beats $(0.26) Estimate, Sales $13.65M Miss $13.85M Estimate
Exagen (NASDAQ:XGN) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.26) by 23.08 percent. This is a 35.48 percent increase over losses of $(0.31) per share from the same
2025-03-11 20:00
Earnings Scheduled For March 11, 2025
Companies Reporting Before The Bell • Exagen (NASDAQ:XGN) is projected to repor...
2025-03-11 16:32
